ChemicalBook > CAS DataBase List > NNC0640

NNC0640

Product Name
NNC0640
CAS No.
307986-98-7
Chemical Name
NNC0640
Synonyms
NNC0640;NNC-0640, 10 mM in DMSO;NNC-0640,Glucagon Receptor,NNC0640,GCGR,inhibit,Inhibitor,NNC 0640;4-((1-(4-Cyclohexylphenyl)-3-(3-(methylsulfonyl)phenyl)ureido)methyl)-N-(1H-tetrazol-5-yl)benzamide;Benzamide, 4-[[(4-cyclohexylphenyl)[[[3-(methylsulfonyl)phenyl]amino]carbonyl]amino]methyl]-N-2H-tetrazol-5-yl-
CBNumber
CB54718643
Molecular Formula
C29H31N7O4S
Formula Weight
573.67
MOL File
307986-98-7.mol
More
Less

NNC0640 Property

storage temp. 
Store at -20°C
solubility 
DMSO:57.37(Max Conc. mg/mL);100.0(Max Conc. mM)
form 
Solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Tocris
Product number
6807
Product name
NNC0640
Purity
≥98%(HPLC)
Packaging
10
Price
$215
Updated
2021/12/16
Tocris
Product number
6807
Product name
NNC0640
Purity
≥98%(HPLC)
Packaging
50
Price
$905
Updated
2021/12/16
ChemScene
Product number
CS-0087150
Product name
NNC-0640
Purity
98.48%
Packaging
5mg
Price
$390
Updated
2021/12/16
More
Less

NNC0640 Chemical Properties,Usage,Production

Description

NNC0640 is a negative allosteric modulator of glucagon-like peptide-1 receptor (GLP-1R).

in vitro

Crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 ? resolution, respectively were reported. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling._x000D_ _x000D_ Reference: Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu ZJ, Wang MW, Stevens RC. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature. 2017 Jun 8;546(7657):312-315. doi: 10.1038/nature22378. Epub 2017 May 17. PMID: 28514449.

target

Glucagon receptors (pKi = 7.4).

storage

Store at -20°C

NNC0640 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NNC0640 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32159
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38630
Advantage
58

307986-98-7, NNC0640Related Search:


  • NNC0640
  • Benzamide, 4-[[(4-cyclohexylphenyl)[[[3-(methylsulfonyl)phenyl]amino]carbonyl]amino]methyl]-N-2H-tetrazol-5-yl-
  • NNC-0640,Glucagon Receptor,NNC0640,GCGR,inhibit,Inhibitor,NNC 0640
  • 4-((1-(4-Cyclohexylphenyl)-3-(3-(methylsulfonyl)phenyl)ureido)methyl)-N-(1H-tetrazol-5-yl)benzamide
  • NNC-0640, 10 mM in DMSO
  • 307986-98-7
  • C29H31N7O4S